Geode Capital Management’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
VCM
VFT
PP
XT
VF
Geode Capital Management's BCDA Position: Q1 2026 in Review
Geode Capital Management increased its BioCardia (BCDA) stake by 43% in Q1 2026, buying an estimated $35.4K and bringing the position to 94,287 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4100.
Geode Capital Management first reported a position in BCDA in Q4 2020 and has held it in 22 quarters since. The position peaked at $388K in Q2 2023. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.
- Geode Capital Management held 94,287 shares of BioCardia worth $114K as of Q1 2026.
- Geode Capital Management bought 28,284 BioCardia shares in Q1 2026, an estimated $35.4K.
- BioCardia made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4100 holding.
- Geode Capital Management first reported a position in BioCardia in Q4 2020 and has held it in 22 quarters since.
- Geode Capital Management's BioCardia position peaked at $388K in Q2 2023.
- 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.